Literature DB >> 6134554

Differential effects of altered hormonal state on the induction of acyl-CoA hydrolases and peroxisomal beta-oxidation by clofibric acid.

Y Kawashima, H Katoh, H Kozuka.   

Abstract

Induction of hydrolase I, hydrolase II, peroxisomal beta-oxidation and hepatomegaly caused by clofibric acid (rho-chlorophenoxyisobutyric acid) administration was investigated in relation to alterations in hormonal state of glucocorticoid, thyroid hormone and insulin. (1) In adrenalectomized rats, the ability to induce hydrolase I was depressed effectively and little hepatomegaly was produced. Hydrolase II and peroxisomal beta-oxidation were induced to a similar extent, compared to those of intact rats. (2) In hypothyroid rats, induction of hydrolase I, hydrolase II, peroxisomal beta-oxidation and hepatomegaly was reduced. In hyperthyroid rats, the ability to induce hydrolase I, hydrolase II and peroxisomal beta-oxidation was depressed, although hepatomegaly was produced by the same or a greater extent as in intact rats. (3) In diabetic rats, marked reduction of ability to induce both hydrolase I and II was observed and induction of hepatomegaly was depressed slightly, although peroxisomal beta-oxidation was induced normally. Differences in the response of four parameters (hydrolase I, hydrolase II, peroxisomal beta-oxidation and liver size) to alterations in hormonal state suggest that the four biological responses to clofibric acid may each be mediated through distinct mechanism(s) other and regulated by distinct hormone(s).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134554     DOI: 10.1016/0005-2760(83)90041-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Peroxisome proliferator-induced acyl-CoA thioesterase from rat liver cytosol: molecular cloning and functional expression in Chinese hamster ovary cells.

Authors:  S T Engberg; T Aoyama; S E Alexson; T Hashimoto; L T Svensson
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

2.  Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver.

Authors:  Y Kawashima; N Uy-Yu; H Kozuka
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Molecular cloning and characterization of a mitochondrial peroxisome proliferator-induced acyl-CoA thioesterase from rat liver.

Authors:  L T Svensson; S T Engberg; T Aoyama; N Usuda; S E Alexson; T Hashimoto
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

4.  A luminometric assay for peroxisomal beta-oxidation. Effects of fasting and streptozotocin-diabetes on peroxisomal beta-oxidation.

Authors:  H Osmundsen; B Brodal; R Hovik
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

5.  Chiral inversion of (R)-(-)-fenoprofen in guinea-pigs pretreated with clofibrate.

Authors:  M F San Martín; A Soraci; F Fogel; O Tapia; S Islas
Journal:  Vet Res Commun       Date:  2002-06       Impact factor: 2.459

6.  Regulation of hepatic level of fatty-acid-binding protein by hormones and clofibric acid in the rat.

Authors:  S Nakagawa; Y Kawashima; A Hirose; H Kozuka
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

7.  Effect of clofibric acid on the molecular species composition of diacyl glycerophosphocholine of rat liver microsomes.

Authors:  Y Nakagawa; K Waku; A Hirose; Y Kawashima; H Kozuka
Journal:  Lipids       Date:  1986-10       Impact factor: 1.880

8.  Alterations by peroxisome proliferators of acyl composition of hepatic phosphatidylcholine in rats, mice and guinea-pigs. Role of stearoyl-CoA desaturase.

Authors:  Y Kawashima; A Hirose; H Kozuka
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

9.  Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.

Authors:  Michael L Cunningham; Bradley J Collins; Milton R Hejtmancik; Ronald A Herbert; Gregory S Travlos; Molly K Vallant; Matthew D Stout
Journal:  PPAR Res       Date:  2010-10-04       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.